Related references
Note: Only part of the references are listed.Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Hyuna Sung et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2021)
Accumulation of Genetic and Epigenetic Alterations in the Background Liver and Emergence of Hepatocellular Carcinoma in Patients with Non-Alcoholic Fatty Liver Disease
Satoru Hagiwara et al.
CELLS (2021)
p53 Mutation at Serine 249 and Its Gain of Function Are Highly Related to Hepatocellular Carcinoma after Smoking Exposure
Huai Wang et al.
PUBLIC HEALTH GENOMICS (2021)
Kinesin family member 2C promotes hepatocellular carcinoma growth and metastasis via activating MEK/ERK pathway
Qian Ding et al.
BIOSCIENCE BIOTECHNOLOGY AND BIOCHEMISTRY (2021)
P120 and E-cadherin: Double-edged swords in tumor metastasis
Jan-Hendrik Venhuizen et al.
SEMINARS IN CANCER BIOLOGY (2020)
A polysaccharide from Grifola frondosa fruit body induces HT-29 cells apoptosis by PI3K/AKT-MAPKs and NF-κB-pathway
Nana Bie et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES (2020)
Effects of Ketoconazole on ACTH-Producing and Non-ACTH-Producing Neuroendocrine Tumor Cells
Aura D. Herrera-Martinez et al.
HORMONES & CANCER (2019)
Ketoconazole exacerbates mitophagy to induce apoptosis by downregulating cyclooxygenase-2 in hepatocellular carcinoma
Yan Chen et al.
JOURNAL OF HEPATOLOGY (2019)
LKB1 signaling is activated in CTNNB1-mutated HCC and positively regulates β-catenin-dependent CTNNB1-mutated HCC
Sara Charawi et al.
JOURNAL OF PATHOLOGY (2019)
Oral chemotherapy for the treatment of hepatocellular carcinoma
Shun Yamamoto et al.
EXPERT OPINION ON PHARMACOTHERAPY (2018)
EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma
Peter R. Galle et al.
JOURNAL OF HEPATOLOGY (2018)
Lack of hepatic stimulator substance expression promotes hepatocellular carcinoma metastasis partly through ERK-activated epithelial-mesenchymal transition
Xiao-wei Jia et al.
LABORATORY INVESTIGATION (2018)
HEPATOCELLULAR CARCINOMA IN 2017 Two large steps forward, one small step back
Marcus-Alexander Woerns et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2018)
HCC-derived exosomes elicit HCC progression and recurrence by epithelialmesenchymal transition through MAPK/ ERK signalling pathway
Lu Chen et al.
CELL DEATH & DISEASE (2018)
Imidazole Antifungal Drugs Inhibit the Cell Proliferation and Invasion of Human Breast Cancer Cells
Sung Hun Bae et al.
BIOMOLECULES & THERAPEUTICS (2018)
The role of ketoconazole in current prostate cancer care
Vaibhav Patel et al.
NATURE REVIEWS UROLOGY (2018)
Serine protease inhibitor Kazal type 1 (SPINK1) downregulates E-cadherin and induces EMT of hepatoma cells to promote hepatocellular carcinoma metastasis via the MEK/ERK signaling pathway
Hai Yan Ying et al.
JOURNAL OF DIGESTIVE DISEASES (2017)
The Burden of Primary Liver Cancer and Underlying Etiologies From 1990 to 2015 at the Global, Regional, and National Level Results From the Global Burden of Disease Study 2015
Tomi Akinyemiju et al.
JAMA ONCOLOGY (2017)
Synthesis, antifungal and antitumor activity of two new types of imidazolin-2-ones
Shaopeng Wei et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2017)
Membrane Proteome-Wide Response to the Antifungal Drug Clotrimazole in Candida glabrata: Role of the Transcription Factor CgPdr1 and the Drug: H plus Antiporters CgTpo1_1 and CgTpo1_2
Pedro Pais et al.
MOLECULAR & CELLULAR PROTEOMICS (2016)
New imidazolidineiminothione derivatives: Synthesis, spectral characterization and evaluation of antitumor, antiviral, antibacterial. and antifungal activities
Ziad Moussa et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2016)
Epithelial-to-mesenchymal plasticity of cancer stem cells: therapeutic targets in hepatocellular carcinoma
Aparna Jayachandran et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2016)
Treatment of hepatocellular carcinoma: beyond international guidelines
Angelo Sangiovanni et al.
LIVER INTERNATIONAL (2016)
Phosphatidylinositol-3-kinase as a putative target for anticancer action of clotrimazole
Cristiane M. Furtado et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2015)
Prospective evaluation of low-dose ketoconazole plus hydrocortisone in docetaxel pre-treated castration-resistant prostate cancer patients
E. N. Lo et al.
PROSTATE CANCER AND PROSTATIC DISEASES (2015)
Clotrimazole Preferentially Inhibits Human Breast Cancer Cell Proliferation, Viability and Glycolysis
Cristiane M. Furtado et al.
PLOS ONE (2012)
Tumor Metastasis: Molecular Insights and Evolving Paradigms
Scott Valastyan et al.
CELL (2011)
Hallmarks of Cancer: The Next Generation
Douglas Hanahan et al.
CELL (2011)
Clotrimazole disrupts glycolysis in human breast cancer without affecting non-tumoral tissues
Raquel Guimaraes Coelho et al.
MOLECULAR GENETICS AND METABOLISM (2011)
Pharmacokinetics and pharmacodynamics of docetaxel with or without ketoconazole modulation in chemonaive breast cancer patients
Y. -W. Lim et al.
ANNALS OF ONCOLOGY (2010)
Clotrimazole decreases human breast cancer cells viability through alterations in cytoskeleton-associated glycolytic enzymes
DD Meira et al.
MOLECULAR GENETICS AND METABOLISM (2005)
Surgical strategy for hepatocellular carcinoma originating in the caudate lobe
T Yamamoto et al.
SURGERY (2004)
Share Paper
